SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-209074
Filing Date
2015-06-01
Accepted
2015-06-01 16:17:33
Documents
5
Period of Report
2015-05-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d934067d8k.htm 8-K 14581
2 EX-99.1 d934067dex991.htm EX-99.1 19495
3 EX-99.2 d934067dex992.htm EX-99.2 26659
4 GRAPHIC g934067ex99_1logo.jpg GRAPHIC 9782
5 GRAPHIC g934067g72g29.gif GRAPHIC 4381
  Complete submission text file 0001193125-15-209074.txt   81657
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 15903591
SIC: 2834 Pharmaceutical Preparations